Zvi Ben-David
Direttore Finanziario/CFO presso DARIOHEALTH CORP.
Patrimonio netto: 773 852 $ in data 31/05/2024
Posizioni attive di Zvi Ben-David
Società | Posizione | Inizio | Fine |
---|---|---|---|
DARIOHEALTH CORP. | Direttore Finanziario/CFO | 07/01/2015 | - |
Segretario Aziendale | 07/01/2015 | - | |
Treasurer | 07/01/2015 | - | |
Labstyle Innovation Ltd.
Labstyle Innovation Ltd. Electronic Equipment/InstrumentsElectronic Technology Part of DarioHealth Corp., Labstyle Innovation Ltd. is an Israeli company that develops glucose monitoring systems. The company is based in Caesarea, Israel. The company was founded in 2011 by David Weintraub, Shilo Ben-Zeev. | Direttore/Membro del Consiglio | - | - |
PsyInnovations, Inc.
PsyInnovations, Inc. Medical/Nursing ServicesHealth Services PsyInnovations, Inc. provides emotional wellness and behavioral health solutions. Its solutions include provides app-based programs for stress, anxiety and depression based on the science of CBT, along with coaching from mental health professionals. The company was founded by Ritvik Singh, Navya Singh and Stan Miroshnikov in 2015 and is headquartered in New York, NY. | Treasurer | - | - |
Storia della carriera di Zvi Ben-David
Precedenti posizioni note di Zvi Ben-David
Società | Posizione | Inizio | Fine |
---|---|---|---|
UltraShape, Inc.
UltraShape, Inc. Miscellaneous Commercial ServicesCommercial Services UltraShape, Inc. manufactures and markets non-invasive devices for the aesthetic medical field. The company was founded by Betsy S. Atkins and Glicksman Ami in 2000 and is headquartered in San Ramon, CA. | Direttore Finanziario/CFO | 01/01/2005 | 01/01/2012 |
GIBUI HOLDINGS LTD | Direttore Finanziario/CFO | 24/06/2010 | - |
Ultrashape Medical Ltd. | Direttore Finanziario/CFO | 01/01/2005 | 01/01/2012 |
GIVEN IMAGING LTD. | Direttore/Membro del Consiglio | 01/01/1998 | 01/01/2000 |
Direttore Finanziario/CFO | 01/01/1998 | 01/01/2005 | |
Electrochemical Industries Frutarom, Inc. | Corporate Officer/Principal | 01/01/1994 | 01/01/1995 |
UltraShape Ltd.
UltraShape Ltd. Medical SpecialtiesHealth Technology UltraShape redefines aesthetic medicine by developing, manufacturing and marketing innovative non-invasive technologies for fat cell destruction and body sculpting. The company develops and markets clinically proven safe and effective solutions that enhance the lives of patients. The UltraShape proprietary technology employs pulsed (non-thermal) focused ultrasound that instantly, selectively and permanently destroys fat cells without affecting surrounding structures. Founded in 2000, UltraShape has sold Contour I devices in more than 50 countries, demonstrating safety and efficacy. The UltraShape Contour I system, is authorized for marketing outside the U.S. It is the first clinically proven non-invasive solution that offers measurable lasting body sculpting results for men and women with no need for maintenance treatments. The UltraShape system has been shown to be safe and effective in a multi-center controlled trial and numerous other peer-reviewed published independent clinical studies. The device is designed to produce mechanical, non-thermal, acoustic effects which target and selectively destroy (breakdown) fat cells, leaving surrounding critical structures such as skin, blood vessels, nerves, and connective tissue intact. The latest Contour I V3 system uses Vertical Dynamic Focus™ (VDF) pulsed (non-thermal) focused ultrasound that instantly and permanently destroys fat cells providing patients a convenient noninvasive no-downtime solution to reduce localized fat deposits and body circumference. The UltraShape procedure is based on a natural fat clearance process where triglycerides and cell debris from the destroyed fat cells are processed by the body's natural physiological and metabolic pathways. These pathways are the same that handle fat during weight loss. Results from UltraShape's peer-reviewed published multi-center controlled clinical trial and other independent clinical studies show that the released triglycerides do not accumulate to a clinically significant extent in the blood or liver. Over 200,000 patient treatments have been performed worldwide with the Contour I showing high patient satisfaction while demonstrating safety and efficacy. The UltraShape procedure is guided by proprietary real-time tracking and guidance technology designed to deliver smooth, uniform body contouring results. The software guides the operator through a pres-determined treatment algorithm designed to minimize risk of contour irregularities, a common side effect of invasive and non-invasive procedures. The UltraShape procedure is performed during a convenient, 'walk-in, walk-out' session carried out in an office-based environment; it requires no anesthesia or sedation. After treatment, patients immediately resume their daily routines with no need for maintenance treatments. The UltraShape Contour I received the CE Mark in 2005 and a medical device license from Health Canada in 2007. The Contour I system is not available for sale in the U.S; the Contour Plus system is an investigational product limited by U.S. law to investigational use only. | Direttore Finanziario/CFO | - | - |
░░░ ░ ░░░░░░ ░░░░░░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | - | - |
Formazione di Zvi Ben-David
University of Haifa | Undergraduate Degree |
Statistiche
Distribuzione geografica
Israele | 8 |
Stati Uniti | 5 |
Posizioni
Director of Finance/CFO | 7 |
Director/Board Member | 2 |
Treasurer | 2 |
Settori
Electronic Technology | 3 |
Health Technology | 3 |
Finance | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
DARIOHEALTH CORP. | Health Technology |
GIBUI HOLDINGS LTD | Finance |
Aziende private | 8 |
---|---|
Given Imaging Ltd.
Given Imaging Ltd. Electronic Equipment/InstrumentsElectronic Technology Given Imaging Ltd. develops, manufactures, and markets diagnostic products and related medical monitoring equipment. Its solutions include capsule endoscopy, manometry, reflux monitoring and monometry. The company was founded by Gabi Iddan and Gavriel D. Meron in 1998 and is headquartered in Yokneam, Israel. | Electronic Technology |
UltraShape, Inc.
UltraShape, Inc. Miscellaneous Commercial ServicesCommercial Services UltraShape, Inc. manufactures and markets non-invasive devices for the aesthetic medical field. The company was founded by Betsy S. Atkins and Glicksman Ami in 2000 and is headquartered in San Ramon, CA. | Commercial Services |
Electrochemical Industries Frutarom, Inc. | |
RDC - Rafael Development Corp. Ltd.
RDC - Rafael Development Corp. Ltd. Investment ManagersFinance RDC - Rafael Development Corp. Ltd. (RDC - Rafael Development Corp) is a private equity/venture capital subsidiary of Elron Ventures Ltd. founded in 1993. The firm is headquartered in Tel Aviv, Israel. | Finance |
UltraShape Ltd.
UltraShape Ltd. Medical SpecialtiesHealth Technology UltraShape redefines aesthetic medicine by developing, manufacturing and marketing innovative non-invasive technologies for fat cell destruction and body sculpting. The company develops and markets clinically proven safe and effective solutions that enhance the lives of patients. The UltraShape proprietary technology employs pulsed (non-thermal) focused ultrasound that instantly, selectively and permanently destroys fat cells without affecting surrounding structures. Founded in 2000, UltraShape has sold Contour I devices in more than 50 countries, demonstrating safety and efficacy. The UltraShape Contour I system, is authorized for marketing outside the U.S. It is the first clinically proven non-invasive solution that offers measurable lasting body sculpting results for men and women with no need for maintenance treatments. The UltraShape system has been shown to be safe and effective in a multi-center controlled trial and numerous other peer-reviewed published independent clinical studies. The device is designed to produce mechanical, non-thermal, acoustic effects which target and selectively destroy (breakdown) fat cells, leaving surrounding critical structures such as skin, blood vessels, nerves, and connective tissue intact. The latest Contour I V3 system uses Vertical Dynamic Focus™ (VDF) pulsed (non-thermal) focused ultrasound that instantly and permanently destroys fat cells providing patients a convenient noninvasive no-downtime solution to reduce localized fat deposits and body circumference. The UltraShape procedure is based on a natural fat clearance process where triglycerides and cell debris from the destroyed fat cells are processed by the body's natural physiological and metabolic pathways. These pathways are the same that handle fat during weight loss. Results from UltraShape's peer-reviewed published multi-center controlled clinical trial and other independent clinical studies show that the released triglycerides do not accumulate to a clinically significant extent in the blood or liver. Over 200,000 patient treatments have been performed worldwide with the Contour I showing high patient satisfaction while demonstrating safety and efficacy. The UltraShape procedure is guided by proprietary real-time tracking and guidance technology designed to deliver smooth, uniform body contouring results. The software guides the operator through a pres-determined treatment algorithm designed to minimize risk of contour irregularities, a common side effect of invasive and non-invasive procedures. The UltraShape procedure is performed during a convenient, 'walk-in, walk-out' session carried out in an office-based environment; it requires no anesthesia or sedation. After treatment, patients immediately resume their daily routines with no need for maintenance treatments. The UltraShape Contour I received the CE Mark in 2005 and a medical device license from Health Canada in 2007. The Contour I system is not available for sale in the U.S; the Contour Plus system is an investigational product limited by U.S. law to investigational use only. | Health Technology |
PsyInnovations, Inc.
PsyInnovations, Inc. Medical/Nursing ServicesHealth Services PsyInnovations, Inc. provides emotional wellness and behavioral health solutions. Its solutions include provides app-based programs for stress, anxiety and depression based on the science of CBT, along with coaching from mental health professionals. The company was founded by Ritvik Singh, Navya Singh and Stan Miroshnikov in 2015 and is headquartered in New York, NY. | Health Services |
Labstyle Innovation Ltd.
Labstyle Innovation Ltd. Electronic Equipment/InstrumentsElectronic Technology Part of DarioHealth Corp., Labstyle Innovation Ltd. is an Israeli company that develops glucose monitoring systems. The company is based in Caesarea, Israel. The company was founded in 2011 by David Weintraub, Shilo Ben-Zeev. | Electronic Technology |
Ultrashape Medical Ltd. |
- Borsa valori
- Insiders
- Zvi Ben-David
- Esperienza